Procter & Gamble Health Ltd
NSE: PGHL BSE: 500126
₹5015
-47.50 (0.94%)
Wed, 28 Oct 2026, 10:45 pm
Market Cap (in Cr)8354.05
PE Ratio25.46
Dividend3.08
Health Technology
Pharmaceuticals: Major
24.5KProcter & Gamble Health Income Statement
| Particulars | Mar 2005 | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.76B | 3.94B | 3.29B | 3.15B | 3.89B | 4.73B | 5.09B | 5.58B | 6.83B | 7.94B | 8.65B | 9.38B | 9.92B | 6.98B | 8.48B | 9.03B | 10.08B | 11.12B | 12.29B | 12.45B |
| Gross profit | 988.80M | 1.03B | 1.29B | 1.21B | 528.30M | 1.53B | 1.81B | 1.84B | 2.54B | 2.67B | 2.79B | 2.95B | 3.43B | 2.67B | 3.58B | 4.02B | 4.42B | 5.08B | 5.64B | 6.12B |
| Operating expenses (excl. COGS) | -29.20M | -31.80M | -569.10M | -612.40M | -101.40M | -1.00B | -1.28B | -1.52B | -1.61B | -2.04B | -2.34B | -2.33B | -2.42B | -1.90B | -2.30B | -2.05B | -2.19B | -2.64B | -2.63B | -2.02B |
| Selling/general/admin expenses, total | — | — | — | — | — | — | -1.21B | -393.10M | -1.00B | -1.25B | -2.04B | -2.28B | -2.31B | -1.87B | -2.20B | -1.98B | -2.15B | -2.52B | -2.28B | -1.95B |
| Research & development | -2.80M | -5.90M | -7.50M | -9.20M | -11.40M | -14.40M | -20.50M | -28.30M | -50.10M | -86.20M | -110.40M | -121.10M | -4.20M | -35.60M | -162.40M | -57.27M | -39.30M | -65.50M | -57.10M | -34.80M |
| Selling/general/admin expenses, other | — | — | — | — | — | — | -1.19B | -364.80M | -953.50M | -1.16B | -1.93B | -2.15B | -2.30B | -1.84B | -2.04B | -1.92B | -2.11B | -2.45B | -2.23B | -1.91B |
| Other operating expenses, total | -29.20M | -31.80M | -569.10M | -612.40M | -101.40M | -1.00B | -66.90M | -1.12B | -609.10M | -794.50M | -302.50M | -54.50M | -108.40M | -26.20M | -99.10M | -73.93M | -38.40M | -121.20M | -348.10M | -69.47M |
| Operating income | 959.60M | 996.70M | 718.00M | 595.00M | 426.90M | 527.40M | 524.10M | 327.30M | 922.70M | 634.20M | 442.10M | 620.10M | 1.01B | 768.20M | 1.28B | 1.97B | 2.23B | 2.44B | 3.01B | 4.10B |
| Non-operating income, total | 126.20M | 165.40M | 967.00M | 394.80M | 477.00M | 431.80M | 433.00M | 628.60M | 245.20M | 248.30M | 223.50M | 213.20M | 141.30M | 221.00M | 297.50M | 397.27M | 100.60M | 91.90M | 129.10M | 52.93M |
| Interest expense, net of interest capitalized | -1.90M | -200.00K | -100.00K | -100.00K | -100.00K | -300.00K | -700.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.00M | -4.20M | -7.70M | -5.73M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 128.10M | 167.20M | 967.20M | 395.00M | 477.10M | 432.10M | 433.70M | 485.80M | 245.20M | 248.30M | 223.50M | 213.20M | 226.20M | 393.30M | 289.80M | 397.27M | 108.60M | 103.40M | 129.50M | 58.67M |
| Non-operating interest income | 34.20M | 44.10M | 94.30M | 145.70M | 158.20M | 251.60M | 190.20M | 145.60M | 172.40M | 181.40M | 164.80M | 154.70M | 177.20M | 177.00M | 171.90M | 373.20M | 150.60M | 98.80M | 143.30M | 93.87M |
| Miscellaneous non-operating expense | 93.90M | 123.10M | 872.90M | 249.30M | 318.90M | 180.50M | 243.50M | 340.20M | 72.80M | 66.90M | 58.70M | 58.50M | 49.00M | 216.30M | 117.90M | 24.07M | -42.00M | 4.60M | -13.80M | -35.20M |
| Unusual income/expense | — | -1.60M | -100.00K | -100.00K | — | — | — | 142.80M | — | — | — | — | -84.90M | -172.30M | 7.70M | 0 | 0 | -7.30M | 7.30M | 0 |
| Pretax income | 1.09B | 1.16B | 1.69B | 989.80M | 903.90M | 959.20M | 957.10M | 955.90M | 1.17B | 882.50M | 665.60M | 833.30M | 1.15B | 989.20M | 1.58B | 2.37B | 2.33B | 2.53B | 3.14B | 4.15B |
| Taxes | -375.90M | -374.20M | -351.50M | -301.60M | -273.80M | -304.40M | -325.30M | -319.10M | -383.90M | -323.70M | -233.40M | -297.70M | -360.40M | -378.80M | -562.40M | -671.80M | -564.80M | -608.50M | -847.30M | -1.03B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | — | 0 | 0 | 0 | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 709.90M | 787.90M | 1.33B | 688.20M | 630.10M | 654.80M | 631.80M | 636.80M | 784.00M | 558.80M | 432.20M | 535.60M | 791.30M | 610.40M | 1.02B | 1.69B | 1.77B | 1.93B | 2.29B | 3.13B |
| Net income | 709.90M | 787.90M | 1.33B | 688.20M | 630.10M | 654.80M | 631.80M | 636.80M | 784.00M | 558.80M | 432.20M | 535.60M | 791.30M | 939.10M | 8.39B | 1.69B | 1.77B | 1.93B | 2.29B | 3.13B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 709.90M | 787.90M | 1.33B | 688.20M | 630.10M | 654.80M | 631.80M | 636.80M | 784.00M | 558.80M | 432.20M | 535.60M | 791.30M | 939.10M | 8.39B | 1.69B | 1.77B | 1.93B | 2.29B | 3.13B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 1.05B | 1.07B | 782.40M | 660.90M | 484.20M | 602.50M | 737.90M | 406.80M | 1.01B | 734.90M | 568.90M | 854.30M | 1.26B | 959.40M | 1.49B | 2.16B | 2.53B | 2.71B | 3.29B | 4.32B |
| EBIT | 959.60M | 996.70M | 718.00M | 595.00M | 426.90M | 527.40M | 524.10M | 327.30M | 922.70M | 634.20M | 442.10M | 620.10M | 1.01B | 768.20M | 1.28B | 1.97B | 2.23B | 2.44B | 3.01B | 4.10B |
| Total operating expenses | -2.80B | -2.94B | -2.58B | -2.55B | -3.47B | -4.20B | -4.57B | -5.25B | -5.91B | -7.31B | -8.21B | -8.75B | -8.91B | -6.21B | -7.20B | -7.07B | -7.85B | -8.68B | -9.28B | -8.35B |
| Prepaid expenses | 60.90M | 72.20M | 78.30M | 187.20M | 249.60M | 280.00M | 270.50M | 319.60M | 23.40M | 1.27B | 1.28B | 1.29B | 64.50M | 87.30M | 52.50M | 37.50M | 7.70M | 4.90M | 11.70M | 45.10M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | 56.90M | — | 44.20M | 42.10M | 18.00M | 11.00M | 12.00M | 5.60M | 5.50M | 300.00K |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.60M | 0 | 88.80M | 48.10M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 86.90M | 61.70M | 63.10M | 58.50M | 57.50M | 64.60M | — | 66.20M | 68.70M | 78.10M | 76.70M | 104.00M | 0 | 0 | — | 6.40M | 0 | 0 | 0 | 0 |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -168.30M | -168.10M | -251.80M | -504.00M | -168.20M | -294.60M | -1.90B | 0 | 0 | -41.50M | -166.20M | -119.20M | -149.80M | -219.80M | -300.50M | -8.83B | -3.82B | -2.84B | -937.90M | -2.32B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
